Summary
CVS Health Corporation has announced a significant change in its executive leadership team. Effective May 28, 2021, Shawn M. Guertin has been appointed as the new Executive Vice President and Chief Financial Officer (CFO). Mr. Guertin brings extensive experience in financial leadership, having previously served in senior financial roles at Aetna, Coventry Health Care, The Travelers, and UnitedHealthcare. His appointment is accompanied by a comprehensive compensation package, including a substantial base salary, bonus potential, equity awards, and one-time sign-on bonuses. Concurrently, Eva C. Boratto will be departing from her role as Executive Vice President and CFO, also effective May 28, 2021. Ms. Boratto will remain with the company in a non-executive capacity to ensure a smooth transition of her responsibilities. While the material terms of her separation agreement are still to be finalized, her departure marks the end of her tenure as CFO. This leadership transition is a key event for investors to monitor as it may signal strategic shifts or a new direction for the company's financial management.
Key Highlights
- 1Appointment of Shawn M. Guertin as Executive Vice President and Chief Financial Officer, effective May 28, 2021.
- 2Shawn M. Guertin has a strong background in finance, including previous CFO roles at Aetna and Coventry Health Care.
- 3Mr. Guertin's compensation package includes an annual base salary of $1.25 million, a target bonus of 175% of base salary, and target annual equity awards of $7.0 million.
- 4Mr. Guertin will receive a one-time cash sign-on bonus of $1.0 million and a $3.0 million sign-on equity award.
- 5Departure of Eva C. Boratto as Executive Vice President and Chief Financial Officer, effective May 28, 2021.
- 6Ms. Boratto will continue with CVS Health in a non-executive role to aid in the transition.
- 7No family relationships or reportable transactions exist between Mr. Guertin and CVS Health's current officers or directors.